Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine

Vaccine is one of the most promising strategies for cancer immunotherapy; however, there are no therapeutic cancer vaccine achieving significant clinical efficacy till now. The main limiting factors include the immune suppression and escape mechanisms developed by tumor and not enough capacity of va...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qingwen, Hu, Yongmao, Zheng, Peng, Yang, Ying, Fu, Yuting, Duan, Biao, Wang, Mengzhen, Li, Duo, Li, Weiran, He, Jinrong, Zheng, Xiao, Long, Qiong, Ma, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492316/
https://www.ncbi.nlm.nih.gov/pubmed/37684628
http://dx.doi.org/10.1186/s12951-023-02031-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492316/
https://www.ncbi.nlm.nih.gov/pubmed/37684628
http://dx.doi.org/10.1186/s12951-023-02031-w

Ejemplares similares